Srinivas Akkaraju - 12 Feb 2024 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role
Director, 10%+ Owner
Signature
/s/ Srinivas Akkaraju
Issuer symbol
MLYS
Transactions as of
12 Feb 2024
Net transactions value
+$7,499,992
Form type
4
Filing time
14 Feb 2024, 21:07:15 UTC
Previous filing
26 Dec 2023
Next filing
29 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MLYS Common Stock Award $7,499,992 +555,555 +12% $13.50 5,074,916 12 Feb 2024 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities held directly by Samsara BioCapital, L.P. ("Samsara LP"). Dr. Akkaraju has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein.